These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
4. Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. Vianna JL; Haga HJ; Tripathi P; Cervera R; Khamashta MA; Hughes GR Ann Rheum Dis; 1992 Feb; 51(2):160-1. PubMed ID: 1550396 [TBL] [Abstract][Full Text] [Related]
5. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis. Bundhun PK; Soogund MZS; Huang F BMC Pregnancy Childbirth; 2018 Jun; 18(1):212. PubMed ID: 29879927 [TBL] [Abstract][Full Text] [Related]
6. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Tincani A; Andreoli L; Chighizola C; Meroni PL Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269 [TBL] [Abstract][Full Text] [Related]
7. Foetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome. Fehr T; Cathomas G; Weber C; Fontana A; Schaffner A Lupus; 2001; 10(8):576-9. PubMed ID: 11531001 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Kaaja R; Julkunen H; Ammälä P; Palosuo T; Kurki P Acta Obstet Gynecol Scand; 1993 Jan; 72(1):63-6. PubMed ID: 8382439 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121 [TBL] [Abstract][Full Text] [Related]
10. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904 [TBL] [Abstract][Full Text] [Related]
11. [Management of antiphospholipid syndrome]. Saadoun D; Piette JC; Wahl D; Costedoat-Chalumeau N Rev Med Interne; 2012 Apr; 33(4):217-22. PubMed ID: 22360832 [TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
13. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome? Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863 [TBL] [Abstract][Full Text] [Related]
15. [Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus?]. Hachulla E; Leys D; Deleume JF; Pruvo JP; Devulder B Rev Med Interne; 1995; 16(2):121-30. PubMed ID: 7709101 [TBL] [Abstract][Full Text] [Related]
16. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment. de Amorim LC; Maia FM; Rodrigues CE Lupus; 2017 Apr; 26(5):529-536. PubMed ID: 28394226 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360 [TBL] [Abstract][Full Text] [Related]
18. The antiphospholipid syndrome in patients with systemic lupus erythematosus. Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934 [TBL] [Abstract][Full Text] [Related]
19. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. Naarendorp M; Spiera H J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786 [TBL] [Abstract][Full Text] [Related]